Untreated attention-deficit/hyperactivity disorder (ADHD) can lead to substantial adverse
social, economic, and emotional outcomes for patients. The effectiveness of current …

Suboptimal adherence to treatment regimens is a major obstacle to treatment efficacy and
positive outcomes for patients. While poor adherence is common across a variety of chronic …

Objective: To review the literature on the prevalence, potential causes, and consequences of
medication nonadherence in adult attention-deficit/hyperactivity disorder (ADHD) …

Safe and effective medication for attention deficit hyperactivity disorder (ADHD) is available
and recommended as first-line treatment for the core symptoms of inattention, overactivity …

Objective: To develop a descriptive profile of attention-deficit/hyperactivity disorder (ADHD)
pharmacological treatment patterns in terms of persistence, adherence, augmentation …

ADHD is a common neuropsychiatric disorder with a strong persistence over time.
Medication is frequently used in the clinical management of ADHD. After response …

Chronic pediatric health conditions pose a significant challenge for youth, their families and
professionals who treat these conditions. Long-term adherence to interventions, including …

OBJECTIVE: To identify newly treated cases of attention-deficit/hyperactivity disorder
(ADHD), assess the presence of comorbid psychiatric conditions, identify pharmacological …

Attention-deficit/hyperactivity disorder (ADHD) affects approximately 8–10% of school-aged
children in the US and for many individuals persists into adolescence and adulthood. Both …

Rationale The factors underlying the variability in the results of randomized, placebo-
controlled clinical trials (RPCCT) assessing pharmacological interventions for adults with …